Navigation Links
Alcohol helps the brain remember, says new study
Date:4/12/2011

AUSTIN, Texas-Drinking alcohol primes certain areas of our brain to learn and remember better, says a new study from the Waggoner Center for Alcohol and Addiction Research at The University of Texas at Austin.

The common view that drinking is bad for learning and memory isn't wrong, says neurobiologist Hitoshi Morikawa, but it highlights only one side of what ethanol consumption does to the brain.

"Usually, when we talk about learning and memory, we're talking about conscious memory," says Morikawa, whose results were published last month in The Journal of Neuroscience. "Alcohol diminishes our ability to hold on to pieces of information like your colleague's name, or the definition of a word, or where you parked your car this morning. But our subconscious is learning and remembering too, and alcohol may actually increase our capacity to learn, or 'conditionability,' at that level."

Morikawa's study, which found that repeated ethanol exposure enhances synaptic plasticity in a key area in the brain, is further evidence toward an emerging consensus in the neuroscience community that drug and alcohol addiction is fundamentally a learning and memory disorder.

When we drink alcohol (or shoot up heroin, or snort cocaine, or take methamphetamines), our subconscious is learning to consume more. But it doesn't stop there. We become more receptive to forming subsconscious memories and habits with respect to food, music, even people and social situations.

In an important sense, says Morikawa, alcoholics aren't addicted to the experience of pleasure or relief they get from drinking alcohol. They're addicted to the constellation of environmental, behavioral and physiological cues that are reinforced when alcohol triggers the release of dopamine in the brain.

"People commonly think of dopamine as a happy transmitter, or a pleasure transmitter, but more accurately it's a learning transmitter," says Morikawa. "It strengthens those synapses that are active when dopamine is released."

Alcohol, in this model, is the enabler. It hijacks the dopaminergic system, and it tells our brain that what we're doing at that moment is rewarding (and thus worth repeating).

Among the things we learn is that drinking alcohol is rewarding. We also learn that going to the bar, chatting with friends, eating certain foods and listening to certain kinds of music are rewarding. The more often we do these things while drinking, and the more dopamine that gets released, the more "potentiated" the various synapses become and the more we crave the set of experiences and associations that orbit around the alcohol use.

Morikawa's long-term hope is that by understanding the neurobiological underpinnings of addiction better, he can develop anti-addiction drugs that would weaken, rather than strengthen, the key synapses. And if he can do that, he would be able to erase the subconscious memory of addiction.

"We're talking about de-wiring things," says Morikawa. "It's kind of scary because it has the potential to be a mind controlling substance. Our goal, though, is to reverse the mind controlling aspects of addictive drugs."


'/>"/>

Contact: Daniel Oppenheimer
oppenheimer@mail.utexas.edu
512-232-0682
University of Texas at Austin
Source:Eurekalert

Related biology news :

1. New leads on the causes of alcoholism
2. Gene involved in predisposition to alcohol consumption identified
3. New data show non-alcoholic fatty liver disease will reach epidemic status in the US
4. Why some children are harmed by mothers alcohol, but others arent
5. Moderate-to-heavy alcohol intake may increase risk of atrial fibrillation
6. Women involved in leisure activities drink less alcohol
7. Pattern of drinking affects the relation of alcohol intake to coronary heart disease
8. Why are men more susceptible to alcoholism?
9. Alcohol consumers are becoming the norm, UT Southwestern analysis finds
10. International scientific forum on alcohol research
11. Alcohol consumption after breast cancer diagnosis may increase recurrence risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... -- Report Highlights ... The global synthetic-biology market reached nearly $3.9 billion ... at a compound annual growth rate (CAGR) of 24.0% through ... markets for synthetic biology. - Analyses of global market trends, ... compound annual growth rates (CAGRs) through 2021. - Coverage of ...
(Date:2/7/2017)... 7, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... will present at the LEERINK Partners 6th Annual Global ... on Wednesday, February 15, 2017 at 10 a.m. Eastern ... presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  The ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... Feb. 16, 2017  Dermata Therapeutics, LLC, a ... treat a variety of dermatological diseases, today announced ... financing and entered into a $5 million credit ... to use the capital for general corporate purposes ... in the treatment of serious diseases treated by ...
(Date:2/16/2017)... , Feb. 16, 2017  Rhythm, ... rare genetic deficiencies that result in life-threatening ... a $41 million mezzanine round of financing ... OrbiMed, MPM Capital, New Enterprise Associates, Pfizer ... undisclosed public healthcare investment fund. Rhythm will ...
(Date:2/15/2017)... ... February 15, 2017 , ... Park Systems , a leader ... AFM operating software that drastically boosts productivity with single click reliable nanoscale images, is ... functions of setting up and taking the image once done manually by the operator ...
(Date:2/15/2017)... Pa. , Feb. 15, 2017 ... a biotechnology company focused on developing aerosolized KL4 ... it has completed a $10.5 million private placement ... that it has sufficient capital to fund its ... clinical trial data release in mid-2017. ...
Breaking Biology Technology: